We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
For their study, published in The BMJ, data from 62 clinical trials – with a total of 120,000 participants – were examined. There was a small increased risk of self-reported muscle symptoms but these were not associated with clinically confirmed muscle disorders.
Statins were associated with slightly raised chances of liver or kidney dysfunction and eye conditions.
But the paper states that the absolute increases in the risks were “small” and “did not outweigh the reduction in the risk of major cardiovascular events” such as heart attacks and strokes.
Source: Read Full Article
